- Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities
Mu-Su Pan et al, 2020, Chinese Medicine CrossRef - Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells
Shuaishuai Huang et al, 2021, Acta Pharmaceutica CrossRef - Review targeted drug delivery systems for norcantharidin in cancer therapy
Bing-Tao Zhai et al, 2022, Journal of Nanobiotechnology CrossRef - Chrysin inhibit human melanoma A375.S2 cell migration and invasion via affecting MAPK signaling and NF‐κB signaling pathway in vitro
Hsin‐Yu Chen et al, 2019, Environmental Toxicology CrossRef - Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma
Shujie Duan, 2018, Cancer Biomarkers CrossRef - Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro
Jia-Fang Liu et al, 2018, Molecules CrossRef - Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years
Jianbo Zhou et al, 2020, Biomedicine & Pharmacotherapy CrossRef - Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells
Gabriel Martínez-Razo et al, 2023, Pharmaceuticals CrossRef - MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway
Lei Yan et al, 2024, Cell Death Discovery CrossRef - Tumor-Infiltrating iNKT Cells Activated through c-Kit/Sca-1 Are Induced by Pentoxifylline, Norcantharidin, and Their Mixtures for Killing Murine Melanoma Cells
Maximiliano V. M. Correa-Lara et al, 2023, Pharmaceuticals CrossRef - Collateral Damage Intended—Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy
Ana Cavaco et al, 2017, International Journal of Molecular Sciences CrossRef